MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

Home・Akciju saraksts・Smith & Nephew PLC ADR

Smith & Nephew PLC ADR

Slēgts

33.85 -1.05

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

33.75

Max

34.37

Galvenie mērījumi
By Trading Economics
Ienākumi	35M 331M
Pārdošana	203M 3.2B
P/E Sektora vidējais	23.776 63.808
Dividenžu ienesīgums	2.3
Peļņas marža	10.368
Darbinieki	16,988
EBITDA	133M 856M

Rekomendācijas
By TipRanks
Rekomendācijas	Neitrāls
Prognoze 12 mēnešiem	+2.16% upside

Dividendes
By Dow Jones
Dividenžu ienesīgums Sektora vidējais	2.30% 2.38%

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-668M 15B
Iepriekšējā atvēršanas cena	34.9
Iepriekšējā slēgšanas cena	33.85

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

26.64 / 28.37 Atbalsts un pretestība

Smith & Nephew PLC ADR Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 16. apr. 23:26 UTC

Karstas akcijas

Stocks to Watch: Netflix, Alcoa, Knight-Swift, NiSource

2026. g. 16. apr. 20:41 UTC

Galvenie tirgus virzītāji

Netflix Shares Slide After 2Q Outlook Misses Wall Street's Expectations

2026. g. 16. apr. 23:49 UTC

Tirgus saruna

Amplitude's Pivot to Oil-Linked Supply Deal Catches Bull's Eye -- Market Talk

2026. g. 16. apr. 23:45 UTC

Tirgus saruna

Nikkei May Decline After Hitting Record High -- Market Talk

2026. g. 16. apr. 23:33 UTC

Tirgus saruna

Galvenie ziņu notikumi

Gold Edges Higher on Hopes for U.S.-Iran Deal -- Market Talk

2026. g. 16. apr. 22:51 UTC

Tirgus saruna

Netflix Sees Signs That Podcasts May Boost Engagement -- Market Talk

2026. g. 16. apr. 22:08 UTC

Peļņas

Netflix Chair Reed Hastings to Leave Board in June -- 3rd Update

2026. g. 16. apr. 22:06 UTC

Peļņas

Lundin Mining: Earnings From Discontinued Ops in 1Q Expected to Be Positively Impacted by Unaudited Gain on Disposal of Eagle Mine, Totaling Approximately $4M >LUN.T

2026. g. 16. apr. 22:06 UTC

Peļņas

Lundin Mining: Pre-Announces Items Impacting 1Q Results

2026. g. 16. apr. 22:06 UTC

Peļņas

Lundin Mining: Items of Significant Impact in 1Q Expected to Include Unaudited Realized Losses on Derivative Contracts of Approximately $13M, Primarily Related to Gold Collar Contracts >LUN.T

2026. g. 16. apr. 22:06 UTC

Peļņas

Lundin Mining: Rev in 1Q Expected to Be Positively Impacted by Unaudited Provisional Pricing Adjustments on Prior-Period Concentrate Sales of Approximately $22M on Pre-Tax Basis >LUN.T

2026. g. 16. apr. 22:06 UTC

Peļņas

Lundin Mining: Adjustments Primarily Include Upward Adjustments in Relation to Prior-Period Metal Sales >LUN.T

2026. g. 16. apr. 20:50 UTC

Tirgus saruna

Peļņas

Tech, Media & Telecom Roundup: Market Talk

2026. g. 16. apr. 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 16. apr. 20:50 UTC

Tirgus saruna

Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

2026. g. 16. apr. 20:50 UTC

Tirgus saruna

Peļņas

Health Care Roundup: Market Talk

2026. g. 16. apr. 20:49 UTC

Peļņas

SpaceX Is Ready to Go Public. The Stock Market Is Its Rocket. -- Barrons.com

2026. g. 16. apr. 20:43 UTC

Peļņas

Update: Netflix Stock Falls on Weak Guidance. Founder Reed Hastings Is Leaving the Board. -- Barrons.com

2026. g. 16. apr. 20:40 UTC

Tirgus saruna

Peļņas

Global Equities Roundup: Market Talk

2026. g. 16. apr. 20:40 UTC

Tirgus saruna

Peļņas

Netflix Says Engagement Quality Hits New High -- Market Talk

2026. g. 16. apr. 20:30 UTC

Karstas akcijas

Stocks to Watch: TSMC, Abbott Laboratories, Nvidia, Netflix -- WSJ

2026. g. 16. apr. 20:25 UTC

Peļņas

Netflix Stock Falls on Weak Guidance. Founder Reed Hastings Is Leaving the Board. -- Barrons.com

2026. g. 16. apr. 20:23 UTC

Peļņas

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

2026. g. 16. apr. 20:19 UTC

Peļņas

Netflix Guidance Disappoints. The Stock Is Down. -- Barrons.com

2026. g. 16. apr. 20:17 UTC

Peļņas

Alcoa: Alumina Costs in the Aluminum Segment Are Expected to Be Favorable by Approximately $20M Sequentially >AA

2026. g. 16. apr. 20:17 UTC

Peļņas

Alcoa: Based on Higher LME and Midwest Premium Pricing and Expected Higher Shipments, Section 232 Tariff Costs on U.S. Imports of Aluminum From Canada Expected to Increase $35M Sequentially >AA

2026. g. 16. apr. 20:16 UTC

Peļņas

Alcoa: Expects 2026 Total Aluminum Segment Production and Shipments Ranging Between 2.4M and 2.6M Metric Tons, and Between 2.6M and 2.8M Metric Tons, Respectively >AA

2026. g. 16. apr. 20:16 UTC

Peļņas

Alcoa: Expects 2026 Total Aluminum Segment Production and Shipments to Remain Unchanged From Its Prior Projection >AA

2026. g. 16. apr. 20:16 UTC

Peļņas

Alcoa: Expects 2026 Total Alumina Segment Production and Shipments Ranging Between 9.7M to 9.9M Metric Tons, and Between 11.8M and 12.0M Metric Tons, Respectively >AA

2026. g. 16. apr. 20:16 UTC

Peļņas

Alcoa: Expects 2026 Total Alumina Segment Production and Shipments to Remain Unchanged From Prior Projection >AA

Salīdzinājums

Cenas izmaiņa

Smith & Nephew PLC ADR Prognoze

Cenas mērķis

By TipRanks

2.16% augšup

Prognoze 12 mēnešiem

Vidējais 34.96 USD 2.16%

Augstākais 35 USD

Zemākais 34.91 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Smith & Nephew PLC ADR — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

2 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 2 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Smith & Nephew PLC ADR — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

26.64 / 28.37Atbalsts un pretestība

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.